Pay in 4 interest-free payments of $5.80 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Many describe the sensation as comparable to a mosquito bite or a light pinch that lasts only seconds
FDA Submission Timeline Based on the TRIUMPH-4 success and expected 2026 readouts, analysts predict: Late 2026: Completion of core TRIUMPH trials Q4 2026 or Q1 2027: New Drug Application (NDA) submission to FDA Mid to Late 2027: Potential FDA approval Early 2028: Commercial launch Eli Lilly has not officially confirmed these timelines, but the company has indicated it will submit for regulatory approval once sufficient Phase 3 data is available
Adherence to dietary and physical activity recommendations is often unmeasured, making it difficult to isolate medication effects from lifestyle factors
Patients have commonly used compounded GLP-1s because they can be hundreds of dollars cheaper than the brand-name products, although the pharmaceutical companies have started to offer discounted cash prices
